79 related articles for article (PubMed ID: 29552311)
1. MiR-29b reverses oxaliplatin-resistance in colorectal cancer by targeting SIRT1.
Liu H; Cheng XH
Oncotarget; 2018 Feb; 9(15):12304-12315. PubMed ID: 29552311
[TBL] [Abstract][Full Text] [Related]
2. The c-Myc/miR-27b-3p/ATG10 regulatory axis regulates chemoresistance in colorectal cancer.
Sun W; Li J; Zhou L; Han J; Liu R; Zhang H; Ning T; Gao Z; Liu B; Chen X; Ba Y
Theranostics; 2020; 10(5):1981-1996. PubMed ID: 32104496
[TBL] [Abstract][Full Text] [Related]
3. Exosome-delivered circRNA promotes glycolysis to induce chemoresistance through the miR-122-PKM2 axis in colorectal cancer.
Wang X; Zhang H; Yang H; Bai M; Ning T; Deng T; Liu R; Fan Q; Zhu K; Li J; Zhan Y; Ying G; Ba Y
Mol Oncol; 2020 Mar; 14(3):539-555. PubMed ID: 31901148
[TBL] [Abstract][Full Text] [Related]
4. Co-Delivery of Ylang Ylang Oil of
Sedky NK; Abdel-Kader NM; Issa MY; Abdelhady MMM; Shamma SN; Bakowsky U; Fahmy SA
Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37176099
[TBL] [Abstract][Full Text] [Related]
5. Tumor-Derived Exosomal miR-29b Reduces Angiogenesis in Pancreatic Cancer by Silencing ROBO1 and SRGAP2.
Wang L; Yang L; Zhuang T; Shi X
J Immunol Res; 2022; 2022():4769385. PubMed ID: 36277474
[TBL] [Abstract][Full Text] [Related]
6. miR-29b Regulates Lung Cancer Progression by Downregulating FEM1B and Inhibiting the FOX01/AKT Pathway.
Zhang H; Wang R; Deng Q
Comput Math Methods Med; 2022; 2022():3110330. PubMed ID: 36003920
[TBL] [Abstract][Full Text] [Related]
7. MHY2251, a New SIRT1 Inhibitor, Induces Apoptosis via JNK/p53 Pathway in HCT116 Human Colorectal Cancer Cells.
Kang YJ; Kwon YH; Jang JY; Lee JH; Lee S; Park Y; Moon HR; Chung HY; Kim ND
Biomol Ther (Seoul); 2023 Jan; 31(1):73-81. PubMed ID: 35811306
[TBL] [Abstract][Full Text] [Related]
8. Long Noncoding RNA LOC550643 Acts as an Oncogene in the Growth Regulation of Colorectal Cancer Cells.
Wu HF; Lu TJ; Lo YH; Tu YT; Chen YR; Lee MC; Chiang YL; Yeh CY; Tsai KW
Cells; 2022 Mar; 11(7):. PubMed ID: 35406629
[TBL] [Abstract][Full Text] [Related]
9. miRNA Clusters with Up-Regulated Expression in Colorectal Cancer.
Pidíková P; Herichová I
Cancers (Basel); 2021 Jun; 13(12):. PubMed ID: 34198662
[TBL] [Abstract][Full Text] [Related]
10. Advanced bioinformatic analysis and pathway prediction of NSCLC cells upon cisplatin resistance.
Hossian AKMN; Zahra FT; Poudel S; Abshire CF; Polk P; Garai J; Zabaleta J; Mikelis CM; Mattheolabakis G
Sci Rep; 2021 Mar; 11(1):6520. PubMed ID: 33753779
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-Assisted Hormone Cell Signaling in Colorectal Cancer Resistance.
Massaro C; Safadeh E; Sgueglia G; Stunnenberg HG; Altucci L; Dell'Aversana C
Cells; 2020 Dec; 10(1):. PubMed ID: 33396628
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-29b-3p enhances radiosensitivity through modulating WISP1-mediated mitochondrial apoptosis in prostate cancer cells.
Mao A; Tang J; Tang D; Wang F; Liao S; Yuan H; Tian C; Sun C; Si J; Zhang H; Xia X
J Cancer; 2020; 11(21):6356-6364. PubMed ID: 33033519
[TBL] [Abstract][Full Text] [Related]
13. MiR-325 Promotes Oxaliplatin-Induced Cytotoxicity Against Colorectal Cancer Through the HSPA12B/PI3K/AKT/Bcl-2 Pathway.
Zhang L; Chen H; Song Y; Gu Q; Zhang L; Xie Q; Xu J; Zhang M
Dig Dis Sci; 2021 Aug; 66(8):2651-2660. PubMed ID: 32914380
[TBL] [Abstract][Full Text] [Related]
14. MiR-140 Resensitizes Cisplatin-Resistant NSCLC Cells to Cisplatin Treatment Through the SIRT1/ROS/JNK Pathway.
Lin Z; Pan J; Chen L; Wang X; Chen Y
Onco Targets Ther; 2020; 13():8149-8160. PubMed ID: 32884297
[TBL] [Abstract][Full Text] [Related]
15. Insights into the Role of microRNAs in Colorectal Cancer (CRC) Metabolism.
Wai Hon K; Zainal Abidin SA; Othman I; Naidu R
Cancers (Basel); 2020 Aug; 12(9):. PubMed ID: 32878019
[TBL] [Abstract][Full Text] [Related]
16. Overexpressed GATA3 enhances the sensitivity of colorectal cancer cells to oxaliplatin through regulating MiR-29b.
Wang W; Wang M; Xu J; Long F; Zhan X
Cancer Cell Int; 2020; 20():339. PubMed ID: 32760217
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of miR-19a partially reversed the resistance of colorectal cancer to oxaliplatin via PTEN/PI3K/AKT pathway.
Zhang Y; Liu X; Zhang J; Xu Y; Shao J; Hu Y; Shu P; Cheng H
Aging (Albany NY); 2020 Mar; 12(7):5640-5650. PubMed ID: 32209726
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic Delivery of miR-29b Enhances Radiosensitivity in Cervical Cancer.
Zhang T; Xue X; Peng H
Mol Ther; 2019 Jun; 27(6):1183-1194. PubMed ID: 31029553
[TBL] [Abstract][Full Text] [Related]
19. Updates on the epigenetic roles of sirtuins.
Kosciuk T; Wang M; Hong JY; Lin H
Curr Opin Chem Biol; 2019 Aug; 51():18-29. PubMed ID: 30875552
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-mediated redox regulation modulates therapy resistance in cancer cells: clinical perspectives.
Ebrahimi S; Hashemy SI
Cell Oncol (Dordr); 2019 Apr; 42(2):131-141. PubMed ID: 30645730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
